480 related articles for article (PubMed ID: 17062245)
1. Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant.
Klotz S; Wenzelburger F; Stypmann J; Welp H; Drees G; Schmid C; Scheld HH
Ann Thorac Surg; 2006 Nov; 82(5):1770-3. PubMed ID: 17062245
[TBL] [Abstract][Full Text] [Related]
2. Pre-existing pulmonary hypertension in patients with end-stage heart failure: impact on clinical outcome and hemodynamic follow-up after orthotopic heart transplantation.
Goland S; Czer LS; Kass RM; De Robertis MA; Mirocha J; Coleman B; Capelli C; Raissi S; Cheng W; Fontana G; Trento A
J Heart Lung Transplant; 2007 Apr; 26(4):312-8. PubMed ID: 17403470
[TBL] [Abstract][Full Text] [Related]
3. Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation.
Butler J; Stankewicz MA; Wu J; Chomsky DB; Howser RL; Khadim G; Davis SF; Pierson RN; Wilson JR
J Heart Lung Transplant; 2005 Feb; 24(2):170-7. PubMed ID: 15701433
[TBL] [Abstract][Full Text] [Related]
4. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
von Scheidt W; Costard-Jaeckle A; Stempfle HU; Deng MC; Schwaab B; Haaff B; Naegele H; Mohacsi P; Trautnitz M;
J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468
[TBL] [Abstract][Full Text] [Related]
6. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation.
Erickson KW; Costanzo-Nordin MR; O'Sullivan EJ; Johnson MR; Zucker MJ; Pifarré R; Lawless CE; Robinson JA; Scanlon PJ
J Heart Transplant; 1990; 9(5):526-37. PubMed ID: 2231091
[TBL] [Abstract][Full Text] [Related]
7. Inhaled nitric oxide through a noninvasive ventilation device to assess reversibility of pulmonary hypertension in selecting recipients for heart transplant.
Fojón S; Fernández-González C; Sánchez-Andrade J; López-Pérez JM; Hermida LF; Rodríguez JA; Juffé A
Transplant Proc; 2005 Nov; 37(9):4028-30. PubMed ID: 16386617
[TBL] [Abstract][Full Text] [Related]
8. Is the transpulmonary pressure gradient a predictor for mortality after orthotopic cardiac transplantation?
Gorlitzer M; Ankersmit J; Fiegl N; Meinhart J; Lanzenberger M; Unal K; Dunkler D; Kilo J; Wolner E; Grimm M; Grabenwoeger M
Transpl Int; 2005 Apr; 18(4):390-5. PubMed ID: 15773956
[TBL] [Abstract][Full Text] [Related]
9. Reversible pulmonary hypertension in heart transplant candidates--pretransplant evaluation and outcome after orthotopic heart transplantation.
Klotz S; Deng MC; Hanafy D; Schmid C; Stypmann J; Schmidt C; Hammel D; Scheld HH
Eur J Heart Fail; 2003 Oct; 5(5):645-53. PubMed ID: 14607204
[TBL] [Abstract][Full Text] [Related]
10. Effect of reversible pulmonary hypertension on outcomes after heart transplantation.
Drakos SG; Kfoury AG; Gilbert EM; Horne BD; Long JW; Stringham JC; Campbell BA; Renlund DG
J Heart Lung Transplant; 2007 Apr; 26(4):319-23. PubMed ID: 17403471
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidates.
Radovancevic B; Vrtovec B; Thomas CD; Croitoru M; Myers TJ; Radovancevic R; Khan T; Massin EK; Frazier OH
J Heart Lung Transplant; 2005 Jun; 24(6):690-5. PubMed ID: 15949728
[TBL] [Abstract][Full Text] [Related]
12. [Short-term survival after heart transplantation: the relationships between preoperative hemodynamics, organ function and postoperative clinical events].
Frigerio M; Gronda E; Danzi GB; Mangiavacchi M; Oliva F; Quaini E; Trotta E; De Vita C; Pellegrini A
G Ital Cardiol; 1995 Jan; 25(1):1-9. PubMed ID: 7642005
[TBL] [Abstract][Full Text] [Related]
13. Analysis and predictors of pulmonary vascular resistance after cardiac transplantation.
Bourge RC; Kirklin JK; Naftel DC; White C; Mason DA; Epstein AE
J Thorac Cardiovasc Surg; 1991 Mar; 101(3):432-44; discussion 444-5. PubMed ID: 1999936
[TBL] [Abstract][Full Text] [Related]
14. Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices.
Zimpfer D; Zrunek P; Sandner S; Schima H; Grimm M; Zuckermann A; Wolner E; Wieselthaler G
Eur J Cardiothorac Surg; 2007 Apr; 31(4):698-702. PubMed ID: 17289396
[TBL] [Abstract][Full Text] [Related]
15. Prognosis after heart transplant in patients with pulmonary hypertension secondary to cardiopathy.
Mogollón MV; Lage Gallé E; Hinojosa Pérez R; Herruzo Avilés A; Sobrino Márquez JM; Romero Rodríguez N; Martínez Martínez A
Transplant Proc; 2008 Nov; 40(9):3031-3. PubMed ID: 19010182
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of pulmonary hypertension reversibility test with sodium nitroprusside in stratification of early death risk after orthotopic heart transplantation.
Zakliczynski M; Zebik T; Maruszewski M; Swierad M; Zembala M
Transplant Proc; 2005 Mar; 37(2):1346-8. PubMed ID: 15848716
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation.
Krowka MJ; Plevak DJ; Findlay JY; Rosen CB; Wiesner RH; Krom RA
Liver Transpl; 2000 Jul; 6(4):443-50. PubMed ID: 10915166
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
Zimpfer D; Zrunek P; Roethy W; Czerny M; Schima H; Huber L; Grimm M; Rajek A; Wolner E; Wieselthaler G
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566
[TBL] [Abstract][Full Text] [Related]
19. Effect of different pharmacologic agents to reverse severe pulmonary hypertension among end-stage heart failure patients.
Torres Macho J; Delgado Jimenez JF; Sanz Salvo J; Gonzalez Mansilla A; Sanchez Sanchez V; Gamez Diez S; Escribano Subias P; Saenz de la Calzada C
Transplant Proc; 2009; 41(6):2477-9. PubMed ID: 19715956
[TBL] [Abstract][Full Text] [Related]
20. Comparison between two drugs on the hemodynamic evaluation of pulmonary hypertension prior to heart transplantation.
Mogollón Jiménez MV; Escoresca Ortega AM; Hinojosa Pérez R; Lage Gallé E; Herruzo Avilés A; Sobrino Márquez M; Frutos López M; Romero Rodríguez N; Pérez de la Yglesia R; Martínez Martínez A
Transplant Proc; 2008 Nov; 40(9):3009-11. PubMed ID: 19010174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
